Savara Inc Contracts & Agreements

Amendment No. 2 to the Manufacture and Supply Agreement, dated December 13, 2023 entered into by and between Savara ApS GEMABIOTECH SAU (Filed With SEC on March 7, 2024)

Underwriting Agreement, dated July 12, 2023, by and among Savara Inc., Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters named therein (Filed With SEC on July 13, 2023)

Form of Pre-Funded Warrant (Filed With SEC on July 13, 2023)

Executive Employment Agreement, dated February 13, 2023, between Savara Inc. and Robert Lutz (Filed With SEC on February 14, 2023)

Amended and Restated Executive Employment Agreement, dated December 13, 2022, between Savara Inc. and Matthew Pauls (Filed With SEC on December 15, 2022)

Amended and Restated Executive Employment Agreement, dated December 13, 2022, between Savara Inc. and David Lowrance (Filed With SEC on December 15, 2022)

Amended and Restated Loan and Security Agreement, dated April 21, 2022, between the Registrant and its subsidiary, Aravas Inc., as borrowers, and Silicon Valley Bank (Filed With SEC on May 11, 2022)

Form of Non-Statutory Stock Option Agreement Under the 2021 Inducement Equity Incentive Plan (Filed With SEC on March 30, 2022)

Form of Restricted Stock Unit Agreement (Inducement Award) Under the 2021 Inducement Equity Incentive Plan (Filed With SEC on March 30, 2022)

Office Lease, dated June 3, 2021, between the Registrant and Overlook at Rob Roy Owner, LLC (Filed With SEC on June 4, 2021)

Master Services Agreement by and between Savara Inc. and Parexel International (IRL) Limited, effective January 6, 2021 (Filed With SEC on May 13, 2021)

Work Order under Master Services Agreement by and between Savara Inc. and Parexel International (IRL) Limited, effective January 6, 2021 (Filed With SEC on May 13, 2021)

Fourth Amendment, dated March 30, 2021, to Loan and Security Agreement, dated April 28, 2017, as amended on October 31, 2017, December 4, 2018 and January 31, 2021, between the... (Filed With SEC on April 1, 2021)

Underwriting Agreement, dated March 11, 2021, by and among Savara Inc., Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters named therein (Filed With SEC on March 11, 2021)

Form of Pre-Funded Warrant (Filed With SEC on March 11, 2021)

Form of Warrant Repurchase Agreement (Filed With SEC on March 11, 2021)

Form of Incentive Stock Option Grant Agreement Exempt Employees, in accordance with Danish employment law, under the 2015 Omnibus Incentive Plan (Filed With SEC on March 10, 2021)

Executive Employment Agreement, dated March 9, 2021, between Savara Inc. and Badrul Chowdhury (Filed With SEC on March 10, 2021)

Amended and Restated Executive Employment Agreement, dated December 8, 2020, between Savara Inc. and Matthew Pauls (Filed With SEC on December 10, 2020)

Executive Employment Agreement, dated September 11, 2020, between Savara Inc. and Matthew Pauls (Filed With SEC on September 11, 2020)

Savara Inc. Amended and Restated 2015 Omnibus Incentive Plan, as amended (Filed With SEC on June 1, 2020)

License and Collaboration Agreement between Savara Inc. and Grifols, S.A, dated January 7, 2020, as amended by Amendment No. 1, dated February 18, 2020, and Amendment No. 2, dated... (Filed With SEC on May 7, 2020)

Description of Registered Securities (Filed With SEC on March 12, 2020)

Restricted Stock Unit Agreement (Inducement Grant) between Badrul Chowdhury and Savara Inc. dated November 26, 2019 (Filed With SEC on March 12, 2020)

Non-statutory Stock Option Agreement (Inducement Award) between Badrul Chowdhury and Savara Inc. dated November 26, 2019 (Filed With SEC on March 12, 2020)

Executive Employment Agreement, dated September 6, 2019, between Savara Inc. and Badrul Chowdhury, Chief Medical Officer (Filed With SEC on March 12, 2020)

Second Amendment to Warrant to Purchase Common Stock dated January 31, 2020, to Warrant to Purchase Common Stock of the Registrant issued to Life Science Loans II, LLC on April... (Filed With SEC on February 3, 2020)

Second Amendment to Warrant to Purchase Common Stock dated January 31, 2020, to Warrant to Purchase Common Stock of the Registrant issued to Silicon Valley Bank on April 28, 2017... (Filed With SEC on February 3, 2020)

Amendment to Warrant to Purchase Common Stock of the Registrant dated January 31, 2020, to Warrant to Purchase Common Stock of the Registrant issued to Life Science Loans II, LLC... (Filed With SEC on February 3, 2020)

Amendment to Warrant to Purchase Common Stock of the Registrant dated January 31, 2020, to Warrant to Purchase Common Stock of the Registrant issued to Silicon Valley Bank on June... (Filed With SEC on February 3, 2020)

Amendment to Warrant to Purchase Common Stock of the Registrant dated January 31, 2020, to Warrant to Purchase Common Stock of the Registrant issued to Life Science Loans II, LLC... (Filed With SEC on February 3, 2020)

Amendment to Warrant to Purchase Common Stock of the Registrant dated January 31, 2020, to Warrant to Purchase Common Stock of the Registrant issued to Silicon Valley Bank on... (Filed With SEC on February 3, 2020)

Third Amendment, dated January 31, 2020, to Loan and Security Agreement, dated April 28, 2017, as amended on October 31, 2017 and December 4, 2018, among the Registrant, Aravas... (Filed With SEC on February 3, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on December 20, 2019)

Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on December 20, 2019)

Securities Purchase Agreement, dated as of December 20, 2019 (Filed With SEC on December 20, 2019)

Registration Rights Agreement, dated as of December 20, 2019 (Filed With SEC on December 20, 2019)

Amendment dated May 27, 2019 to the Business Transfer Agreement Between Savara Inc. and Serendex Pharmaceuticals A/S, dated May 13, 2016, between Savara Inc. and Serendex... (Filed With SEC on August 8, 2019)

Master Manufacturing Services Agreement, dated June 26, 2019, between Savara ApS and Patheon UK Limited (Filed With SEC on August 8, 2019)

Manufacture and Supply Agreement, dated as of April 26, 2019, between Savara ApS and GEMABIOTECH SAU (Filed With SEC on May 9, 2019)

Warrant to Purchase Shares of Common Stock of the Registrant issued to Life Science Loans II, LLC on December 4, 2018 (Filed With SEC on March 13, 2019)

Warrant to Purchase Shares of Common Stock of the Registrant issued to Silicon Valley Bank on December 4, 2018 (Filed With SEC on March 13, 2019)

Second Amendment, dated December 4, 2018, to Loan and Security Agreement, dated April 28, 2017, as amended on October 31, 2017, among Savara Inc., Aravas Inc. and Silicon Valley... (Filed With SEC on March 13, 2019)

Amendment No. 1, effective May 23, 2018, to the Research Collaboration and License Agreement between Savara Inc. (as successor in interest to Serendex Pharmaceuticals A/S) and... (Filed With SEC on August 9, 2018)

Amendment to Executive Employment Agreement, dated as of August 3, 2018, by and among Savara Inc. and Taneli Jouhikainen (Filed With SEC on August 9, 2018)

Amendment to Executive Employment Agreement, dated as of August 3, 2018, by and among Savara Inc. and Dave Lowrance (Filed With SEC on August 9, 2018)

Amendment to Executive Employment Agreement, dated as of August 3, 2018, by and among Savara Inc. and Robert Neville (Filed With SEC on August 9, 2018)

Underwriting Agreement, dated July 26, 2018, by and between Savara Inc. and Jefferies LLC and Evercore Group L.L.C., as representatives of the several underwriters named therein (Filed With SEC on July 26, 2018)

Amendment No. 1 to Common Stock Sales Agreement, dated June 29, 2018, between Savara Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on June 29, 2018)

Savara Inc. 2015 Omnibus Incentive Plan, as amended and restated (Filed With SEC on June 7, 2018)

Form of common stock certificate of the Registrant (Filed With SEC on March 14, 2018)

Form of Non-Statutory Stock Option Grant Agreement General under the 2015 Omnibus Incentive Plan (Filed With SEC on March 14, 2018)

Form of Incentive Stock Option Grant Agreement Exempt Employees, in accordance with Danish employment law, under the 2015 Omnibus Incentive Plan (Filed With SEC on March 14, 2018)

Sublease Agreement between Savara Inc. and Clubessential, LLC dated November 28, 2017 (Filed With SEC on December 4, 2017)

Research Program Award Letter Agreement between Savara Inc. and Cystic Fibrosis Foundation Therapeutics, Inc. dated September 30, 2013, as amended by Amendment No. 1, effective... (Filed With SEC on November 30, 2017)

Settlement Agreement between Savara Inc. and Serenova A/S dated September 1, 2017 (Filed With SEC on November 8, 2017)

Second Addendum, dated September 20, 2017, to the Supply and License Agreement, dated December 10, 2012, between Gemabiotech SAU and Savara ApS (Filed With SEC on November 8, 2017)

Form of Grant of Restricted Stock Units under the 2015 Omnibus Incentive Plan (Filed With SEC on November 8, 2017)

First Amendment, dated October 31, 2017, to Loan and Security Agreement, dated April 28, 2017, among Savara Inc., Aravas Inc. and Silicon Valley Bank (Filed With SEC on November 8, 2017)

Underwriting Agreement, dated October 25, 2017, by and between Savara Inc. and Jefferies LLC, as representative of the several underwriters named therein (Filed With SEC on October 25, 2017)

Form of Pre-Funded Warrant (Filed With SEC on October 25, 2017)

Amendment to Warrant to Purchase Shares of Common Stock of the registrant issued to Life Science Loans II, LLC on June 26, 2017 (Filed With SEC on August 9, 2017)

Amendment to Warrant to Purchase Shares of Common Stock of the registrant issued to SVB Financial Group on June 26, 2017 (Filed With SEC on August 9, 2017)

Warrant to Purchase Shares of Common Stock of the registrant issued to Life Science Loans II, LLC on June 26, 2017 (Filed With SEC on August 9, 2017)

Warrant to Purchase Shares of Common Stock of the registrant issued to Silicon Valley Bank on June 26, 2017 (Filed With SEC on August 9, 2017)

8,421,053 Shares Savara Inc. UNDERWRITING AGREEMENT (Filed With SEC on June 2, 2017)

WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 9, 2017)

LOAN AND SECURITY AGREEMENT (Filed With SEC on May 9, 2017)

SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS (Filed With SEC on May 9, 2017)

CONSULTING SERVICES AGREEMENT (Filed With SEC on May 9, 2017)

SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS (Filed With SEC on May 9, 2017)

CONSULTING SERVICES AGREEMENT (Filed With SEC on May 9, 2017)

SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS (Filed With SEC on May 9, 2017)

SIXTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on April 28, 2017)

SAVARA INC. COMMONSTOCK SALES AGREEMENT (Filed With SEC on April 28, 2017)

SUB-SUBLEASE AGREEMENT (Filed With SEC on March 28, 2017)

THIRD AMENDMENT TO WARRANT AGREEMENT (Filed With SEC on March 6, 2017)

FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 6, 2017)

MAST THERAPEUTICS, INC. NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Filed With SEC on March 6, 2017)

SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS (Filed With SEC on March 6, 2017)

TEMPORARY EMPLOYMENT AGREEMENT (Filed With SEC on March 6, 2017)

SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS (Filed With SEC on March 6, 2017)

[THE REMAINDER OFTHIS PAGE IS INTENTIONALLY LEFT BLANK; THE SIGNATURE PAGE IMMEDIATELY FOLLOWS] (Filed With SEC on February 10, 2017)

SAVARA INC. STOCK PURCHASE WARRANT (Filed With SEC on February 10, 2017)

SAVARA INC. STOCK PURCHASE WARRANT (EXERCISABLE ONLY UPON AN EXERCISE EVENT) (Filed With SEC on February 10, 2017)

MAST THERAPEUTICS, INC. NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Filed With SEC on February 10, 2017)

SAVARA, INC. STOCK OPTION PLAN Effective Date: February 15, 2008 Approved by Stockholders: July 31, 2008 SAVARA, INC. STOCK OPTIONPLAN TABLE OF CONTENTS (Filed With SEC on February 10, 2017)

SAVARA INC. STOCK OPTION PLAN INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on February 10, 2017)

STOCK ISSUANCE AGREEMENT (Filed With SEC on February 10, 2017)

SAVARA INC. March 19, 2012 (Filed With SEC on February 10, 2017)

API SUPPLY AGREEMENT (Vancomycin hydrochloride) (Filed With SEC on February 10, 2017)

SUPPLY AND LICENSE AGREEMENT BETWEEN GEMA Biotech S.A. San Vladimiro 3056, San Isidro, Province of Buenos Aires, Argentina AND Serendex ApS CVR 3053 2228 Slotsmarken 12,1 2970... (Filed With SEC on February 10, 2017)

EXECUTION COPY COMMERCIAL SUPPLY AGREEMENT (Filed With SEC on February 10, 2017)

Execution Copy RESEARCH COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on February 10, 2017)

Mast Therapeutics, Inc. Amendment No. 1 to Lock-Up Agreement January 21, 2017 (Filed With SEC on January 23, 2017)

AGREEMENT AND PLAN OF MERGER AND REORGANIZATION BY AND AMONG MAST THERAPEUTICS, INC., VICTORIA MERGER CORP., AND SAVARA INC., Dated as of January 6, 2017 Table of Contents (Filed With SEC on January 9, 2017)

Voting Agreement (Filed With SEC on January 9, 2017)

Mast Therapeutics, Inc. Lock-Up Agreement January 6, 2017 (Filed With SEC on January 9, 2017)

FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on July 25, 2016)

MAST THERAPEUTICS, INC. EXECUTIVE SEVERANCE AGREEMENT (Filed With SEC on May 6, 2016)

2016 EXECUTIVE INCENTIVE PLAN (Filed With SEC on April 5, 2016)

MAST THERAPEUTICS, INC. EXECUTIVE SEVERANCE AGREEMENT (Filed With SEC on March 25, 2016)

THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on February 29, 2016)

SECOND AMENDMENT TO WARRANT AGREEMENT (Filed With SEC on February 29, 2016)

29,090,910 UNITS, EACHUNIT CONSISTING OF ONE SHARE OF COMMON STOCK AND ONE WARRANT TO PURCHASE ONE SHARE OF COMMON STOCK, OF MAST THERAPEUTICS,INC. UNDERWRITING AGREEMENT (Filed With SEC on February 11, 2016)

[FORM OF WARRANT AGREEMENT] WARRANT AGREEMENT (Filed With SEC on February 11, 2016)

EXERCISABLE ON OR AFTER AUGUST , 2016 AND UNTIL 5:00 P.M. (NEW YORK TIME) ON THE EXPIRATION DATE (Filed With SEC on February 11, 2016)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on January 7, 2016)

LOAN AND SECURITY AGREEMENT (Filed With SEC on November 12, 2015)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 12, 2015)

WARRANT AGREEMENT To Purchase Shares of the Common Stock of MAST THERAPEUTICS, INC. Dated as of August 11, 2015 (the Effective Date) (Filed With SEC on November 12, 2015)

FIRST AMENDMENT TO WARRANT AGREEMENT (Filed With SEC on November 12, 2015)

MAST THERAPEUTICS, INC. $30,000,000 SALESAGREEMENT (Filed With SEC on August 21, 2015)

MAST THERAPEUTICS, INC. 2015 OMNIBUS INCENTIVE PLAN (Filed With SEC on June 16, 2015)

Mast Therapeutics, Inc. 2015 Omnibus Incentive Plan Non-Statutory Stock Option Grant Agreement - Director (Filed With SEC on June 16, 2015)

Mast Therapeutics, Inc. 2015 Omnibus Incentive Plan Incentive Stock Option Grant Agreement Exempt Employees (Filed With SEC on June 16, 2015)

Mast Therapeutics, Inc. 2015 Omnibus Incentive Plan Incentive Stock Option Grant Agreement Non-Exempt Employees (Filed With SEC on June 16, 2015)

Mast Therapeutics, Inc. 2015 Omnibus Incentive Plan CEO Incentive Stock Option Grant Agreement (Filed With SEC on June 16, 2015)

Mast Therapeutics, Inc. 2015 Omnibus Incentive Plan CMO Incentive Stock Option Grant Agreement (Filed With SEC on June 16, 2015)

2015 EXECUTIVE INCENTIVE PLAN (Filed With SEC on June 16, 2015)

MAST THERAPEUTICS, INC. AMENDMENT OF STOCK OPTION AGREEMENTS (Filed With SEC on May 11, 2015)

MAST THERAPEUTICS, INC. DIRECTOR COMPENSATION POLICY (adopted December 11, 2014) (Filed With SEC on March 24, 2015)

30,941,102 Shares of Common Stock Warrants to Purchase 22,011,265 Shares of Common Stock and Pre-FundedWarrants to Purchase 13,081,428 Shares of Common Stock MAST THERAPEUTICS,... (Filed With SEC on November 7, 2014)

PRE-FUNDED WARRANT AGENT AGREEMENT (Filed With SEC on November 7, 2014)

PRE-FUNDED WARRANT MAST THERAPEUTICS, INC. CUSIP NO. (Filed With SEC on November 7, 2014)

WARRANT AGENT AGREEMENT (Filed With SEC on November 7, 2014)

WARRANT MASTTHERAPEUTICS, INC. CUSIP NO. (Filed With SEC on November 7, 2014)

12390 EL CAMINO REAL, SUITE 150 n SAN DIEGO, CA 92130 n TEL ###-###-#### n FAX ###-###-#### n MASTTHERAPEUTICS.COM n NYSE MKT: MSTX (Filed With SEC on October 31, 2014)

SUBLEASE AGREEMENT (Filed With SEC on June 30, 2014)

MAST THERAPEUTICS, INC. 2014 OMNIBUS INCENTIVE PLAN (Filed With SEC on June 20, 2014)

Mast Therapeutics, Inc. 2014 Omnibus Incentive Plan Non-Statutory Stock Option Grant AgreementDirector (Filed With SEC on June 20, 2014)

Mast Therapeutics, Inc. 2014 Omnibus Incentive Plan Incentive Stock Option Grant Agreement (Filed With SEC on June 20, 2014)

Mast Therapeutics, Inc. 2014 Omnibus Incentive Plan Senior Executive Incentive Stock Option Grant Agreement (Filed With SEC on June 20, 2014)

Mast Therapeutics, Inc. 2014 Omnibus Incentive Plan CMO Incentive Stock Option Grant Agreement (Filed With SEC on June 20, 2014)

2014 EXECUTIVE INCENTIVE PLAN (Filed With SEC on June 20, 2014)

AGREEMENT AND PLAN OF MERGER byand among MAST THERAPEUTICS, INC. AP ACQUISITION SUB, INC. and AIRES PHARMACEUTICALS, INC. and FORTIS ADVISORS LLC, in itscapacity as Stockholders... (Filed With SEC on May 5, 2014)

FORM OF STOCKHOLDER AGREEMENT (Filed With SEC on May 5, 2014)

MAST THERAPEUTICS, INC. $30,000,000 SALESAGREEMENT (Filed With SEC on February 10, 2014)

MAST THERAPEUTICS, INC. 2013 OMNIBUS INCENTIVE PLAN (Filed With SEC on June 21, 2013)

Mast Therapeutics, Inc. 2013 Omnibus Incentive Plan Non-Statutory Stock Option Grant Agreement Director (Filed With SEC on June 21, 2013)

Mast Therapeutics, Inc. 2013 Omnibus Incentive Plan Incentive Stock Option Grant Agreement (Filed With SEC on June 21, 2013)

Mast Therapeutics, Inc. 2013 Omnibus Incentive Plan Senior Executive Incentive Stock Option Grant Agreement (Filed With SEC on June 21, 2013)

Mast Therapeutics, Inc. 2013 Omnibus Incentive Plan CMO Incentive Stock Option Grant Agreement (Filed With SEC on June 21, 2013)

50,000,000 Units Each Unit Consisting of One Share of Common Stock And One Warrant to Purchase 0.5 of a Share of Common Stock Mast Therapeutics, Inc. PURCHASE AGREEMENT (Filed With SEC on June 17, 2013)

WARRANT AGENT AGREEMENT (Filed With SEC on June 17, 2013)

[ ] Units Each Unit Consisting of One Share of Common Stock And A Warrant to Purchase [ ] of a Share of Common Stock Mast Therapeutics, Inc. PURCHASE AGREEMENT (Filed With SEC on June 13, 2013)

WARRANT AGENT AGREEMENT (Filed With SEC on June 13, 2013)

[ ] Shares Mast Therapeutics, Inc. Common Stock PURCHASE AGREEMENT (Filed With SEC on June 5, 2013)

MAST THERAPEUTICS, INC. DIRECTOR COMPENSATION POLICY (adopted March 21, 2013) (Filed With SEC on May 15, 2013)

2013 EXECUTIVE INCENTIVE PLAN (Filed With SEC on February 8, 2013)

ADVENTRX PHARMACEUTICALS, INC. CHANGE IN CONTROL SEVERANCE PLAN (Effective as of December 6, 2012) (Filed With SEC on December 7, 2012)

ADVENTRX Pharmaceuticals, Inc. Amended and Restated 2008 Omnibus Incentive Plan Incentive Stock Option Grant Agreement (Filed With SEC on November 5, 2012)

ADVENTRX Pharmaceuticals, Inc. Amended and Restated 2008 Omnibus Incentive Plan Senior Executive Incentive Stock Option Grant Agreement (Filed With SEC on March 8, 2012)

2012 EXECUTIVE INCENTIVE PLAN (Filed With SEC on February 27, 2012)

21,250,000 SHARES of Common Stock and 10,625,000 WARRANTS OF ADVENTRX PHARMACEUTICALS, INC. UNDERWRITING AGREEMENT (Filed With SEC on November 14, 2011)

WARRANT AGENT AGREEMENT (Filed With SEC on November 14, 2011)

COMMON STOCK PURCHASE WARRANT ADVENTRX PHARMACEUTICALS, INC. (Filed With SEC on November 14, 2011)

EX-101 INSTANCE DOCUMENT (Filed With SEC on November 8, 2011)

2011 MID-YEAR EXECUTIVE INCENTIVE PLAN (Filed With SEC on July 8, 2011)

Financial Statements (Filed With SEC on May 9, 2011)

AGREEMENT AND PLAN OF MERGER by and among ADVENTRX PHARMACEUTICALS, INC. SRX ACQUISITION CORPORATION SYNTHRX, INC. and MARTIN EMANUELE, AS STOCKHOLDERS AGENT (Filed With SEC on April 11, 2011)

STOCKHOLDERS VOTING AND TRANSFER RESTRICTION AGREEMENT (Filed With SEC on April 11, 2011)

LICENSE AGREEMENT (Filed With SEC on April 11, 2011)

ADVENTRX Pharmaceuticals, Inc. ACCEPTED AND AGREED:/s/ Patrick Keran /s/ Brandi L. Roberts Patrick Keran President and Chief Operating Officer Brandi L. Roberts Date: 2/14/11 (Filed With SEC on March 22, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 7, 2011)

[SERIES A/B] COMMON STOCK PURCHASE WARRANT (Filed With SEC on January 7, 2011)

Rodman & Renshaw, LLC o 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### o Fax: 212 ###-###-#### o www.rodm.com o Member: FINRA, SIPC (Filed With SEC on January 7, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 3, 2010)

SERIES COMMON STOCK PURCHASE WARRANT (Filed With SEC on May 3, 2010)

Rodman & Renshaw, LLC o 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### o Fax: 212 ###-###-#### o www.rodm.com o Member: FINRA, SIPC (Filed With SEC on May 3, 2010)

reducing the incidence and severity of adverse effects; and (Filed With SEC on March 18, 2010)

ADVENTRX Pharmaceuticals, Inc. 2008 Omnibus Incentive Plan Incentive Stock Option Grant Agreement (Filed With SEC on January 26, 2010)

2010 INCENTIVE PLAN (Filed With SEC on January 26, 2010)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 4, 2010)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on January 4, 2010)

Annex A (Filed With SEC on January 4, 2010)

THIRD AMENDMENT TO STANDARD MULTI-TENANT OFFICE LEASE GROSS (Filed With SEC on December 24, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 5, 2009)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on October 5, 2009)

Rodman& Renshaw, LLC o 1251Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### o Fax: 212 ###-###-#### o www.rodm.com o Member: FINRA, SIPC (Filed With SEC on October 5, 2009)

Reducing the incidence and severity of adverse effects; and (Filed With SEC on September 25, 2009)

THIRD AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on September 1, 2009)

CONSULTING AGREEMENT (Filed With SEC on August 28, 2009)

SECOND AMENDMENT TO STANDARD MULTI-TENANT OFFICE LEASE GROSS (Filed With SEC on August 20, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 5, 2009)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on August 5, 2009)

Annex A (Filed With SEC on August 5, 2009)

ADVENTRX Pharmaceuticals, Inc. 2008 Omnibus Incentive Plan Incentive Stock Option Grant Agreement (Filed With SEC on July 22, 2009)

2009 MID-YEAR INCENTIVE PLAN (Filed With SEC on July 22, 2009)

RETENTION AND SEVERANCE PLAN (as of July 21, 2009) (Filed With SEC on July 22, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 30, 2009)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on June 30, 2009)

Rodman& Renshaw, LLC 1251 Avenue of the Americas, 20thFloor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on June 30, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 8, 2009)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on June 8, 2009)

Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20thFloor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on June 8, 2009)

Current assets (Filed With SEC on May 15, 2009)

Reducing the incidence and severity of adverse effects; and (Filed With SEC on March 27, 2009)

RETENTION AND INCENTIVE AGREEMENT (Filed With SEC on February 2, 2009)

ADVENTRX PHARMACEUTICALS, INC. NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Filed With SEC on February 2, 2009)

ADVENTRX PHARMACEUTICALS, INC. RESTRICTED STOCK UNITS AGREEMENT (Filed With SEC on February 2, 2009)

Current assets (Filed With SEC on August 11, 2008)

ADVENTRX PHARMACEUTICALS, INC. 2008 OMNIBUS INCENTIVE PLAN (Filed With SEC on June 2, 2008)

Current assets (Filed With SEC on May 12, 2008)

ADVENTRX PHARMACEUTICALS, INC. CONSULTING AGREEMENT (Filed With SEC on April 16, 2008)

Improving their safety and reducing the incidence and severity of adverse effects; and (Filed With SEC on March 17, 2008)

SECOND AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on February 25, 2008)

Current assets (Filed With SEC on May 8, 2007)

Enhancing their effectiveness (Filed With SEC on March 15, 2007)

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on December 20, 2006)

Opinion of Heller Ehrman LLP (Filed With SEC on November 3, 2006)

License Agreement, dated as of October 20, 2006, by and between ADVENTRX Pharmaceuticals, Inc., through its wholly-owned subsidiary SD Pharmaceuticals, Inc., and Theragenex, LLC (Filed With SEC on October 23, 2006)

FIRST AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on September 22, 2006)

ADVENTRX Pharmaceuticals, Inc. ACCEPTED AND AGREED: /s/ Evan Levine Evan Levine /s/ James Merritt Chief Executive Officer James Merritt, M.D. Date: September 7, 2006 (Filed With SEC on September 8, 2006)

SEVERANCE AGREEMENT AND RELEASE OF ALL CLAIMS (Filed With SEC on September 8, 2006)

ADVENTRX PHARMACEUTICALS, INC. (Filed With SEC on September 8, 2006)

Financial Statements of Business Acquired (Filed With SEC on May 1, 2006)

Development Stage (Filed With SEC on March 16, 2006)

Current assets (Filed With SEC on November 14, 2005)

Current assets (Filed With SEC on August 12, 2005)

Category

Industry

Companies

Contracts

Savara Inc Contracts & Agreements